ETHACRYNIC ACID Drug Patent Profile
✉ Email this page to a colleague
When do Ethacrynic Acid patents expire, and what generic alternatives are available?
Ethacrynic Acid is a drug marketed by Adaptis, Agnitio, Alvogen, Amneal Pharms Co, Chartwell Rx, Endo Operations, Hikma, Lupin Ltd, Sciegen Pharms Inc, and Upsher Smith Labs. and is included in ten NDAs.
The generic ingredient in ETHACRYNIC ACID is ethacrynic acid. There are thirteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the ethacrynic acid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ethacrynic Acid
A generic version of ETHACRYNIC ACID was approved as ethacrynic acid by ADAPTIS on June 30th, 2016.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ETHACRYNIC ACID?
- What are the global sales for ETHACRYNIC ACID?
- What is Average Wholesale Price for ETHACRYNIC ACID?
Summary for ETHACRYNIC ACID
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 10 |
| Finished Product Suppliers / Packagers: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 82 |
| Clinical Trials: | 4 |
| Patent Applications: | 5,268 |
| Drug Prices: | Drug price information for ETHACRYNIC ACID |
| DailyMed Link: | ETHACRYNIC ACID at DailyMed |
Recent Clinical Trials for ETHACRYNIC ACID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Pari Pharma GmbH | Phase 1 |
| Neupharma Srl | Phase 1 |
| Centro Ricerche Cliniche di Verona | Phase 1 |
Pharmacology for ETHACRYNIC ACID
| Drug Class | Loop Diuretic |
| Physiological Effect | Increased Diuresis at Loop of Henle |
Medical Subject Heading (MeSH) Categories for ETHACRYNIC ACID
US Patents and Regulatory Information for ETHACRYNIC ACID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adaptis | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 205609-001 | Jun 30, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hikma | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 207262-001 | Feb 23, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Amneal Pharms Co | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 208805-001 | May 8, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Lupin Ltd | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 211719-001 | Sep 6, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Agnitio | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 211809-001 | Jul 12, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Alvogen | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 205709-001 | Jul 24, 2018 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Endo Operations | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 208501-001 | Jul 21, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
